Lonza Group AG (LONN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.085x

Based on the latest financial reports, Lonza Group AG (LONN) has a cash flow conversion efficiency ratio of 0.085x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF783.00 Million ≈ $989.92 Million USD) by net assets (CHF9.19 Billion ≈ $11.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LONN net asset quality score to measure how much of total assets are equity-financed.

Lonza Group AG - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Lonza Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Lonza Group AG earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Lonza Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lonza Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Roblox Corp
NYSE:RBLX
1.400x
Vodafone Group Plc
MX:VODN
0.108x
Shandong Hongchuang Aluminum Industry Holding Co Ltd
SHE:002379
-0.013x
United Microelectronics Corporation
F:UMCB
0.054x
Live Nation Entertainment Inc
NYSE:LYV
-0.048x
ENDESA ADR/ 1/2 EO 120
F:ENAA
0.108x
AngloGold Ashanti Ltd
JSE:ANG
0.165x
Kimberly-Clark Corporation
NYSE:KMB
0.532x

Annual Cash Flow Conversion Efficiency for Lonza Group AG (2004–2025)

The table below shows the annual cash flow conversion efficiency of Lonza Group AG from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see LONN stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CHF9.19 Billion
≈ $11.61 Billion
CHF1.17 Billion
≈ $1.48 Billion
0.127x -6.23%
2024-12-31 CHF9.39 Billion
≈ $11.87 Billion
CHF1.27 Billion
≈ $1.61 Billion
0.136x -6.80%
2023-12-31 CHF9.51 Billion
≈ $12.03 Billion
CHF1.39 Billion
≈ $1.75 Billion
0.146x +52.24%
2022-12-31 CHF10.66 Billion
≈ $13.48 Billion
CHF1.02 Billion
≈ $1.29 Billion
0.096x -22.80%
2021-12-31 CHF9.82 Billion
≈ $12.42 Billion
CHF1.22 Billion
≈ $1.54 Billion
0.124x -24.52%
2020-12-31 CHF6.88 Billion
≈ $8.70 Billion
CHF1.13 Billion
≈ $1.43 Billion
0.164x +9.29%
2019-12-31 CHF6.57 Billion
≈ $8.30 Billion
CHF986.00 Million
≈ $1.25 Billion
0.150x -12.69%
2018-12-31 CHF6.29 Billion
≈ $7.95 Billion
CHF1.08 Billion
≈ $1.37 Billion
0.172x +26.43%
2017-12-31 CHF6.18 Billion
≈ $7.81 Billion
CHF841.00 Million
≈ $1.06 Billion
0.136x -57.39%
2016-12-31 CHF2.35 Billion
≈ $2.98 Billion
CHF752.00 Million
≈ $950.73 Million
0.319x -8.00%
2015-12-31 CHF2.13 Billion
≈ $2.70 Billion
CHF741.00 Million
≈ $936.82 Million
0.347x +53.06%
2014-12-31 CHF2.13 Billion
≈ $2.69 Billion
CHF483.00 Million
≈ $610.64 Million
0.227x -7.65%
2013-12-31 CHF2.13 Billion
≈ $2.69 Billion
CHF522.00 Million
≈ $659.95 Million
0.246x -16.80%
2012-12-31 CHF2.41 Billion
≈ $3.04 Billion
CHF710.00 Million
≈ $897.63 Million
0.295x +214.59%
2011-12-31 CHF2.36 Billion
≈ $2.98 Billion
CHF221.00 Million
≈ $279.40 Million
0.094x -55.40%
2010-12-31 CHF2.39 Billion
≈ $3.02 Billion
CHF502.00 Million
≈ $634.66 Million
0.210x +19.06%
2009-12-31 CHF2.39 Billion
≈ $3.02 Billion
CHF422.00 Million
≈ $533.52 Million
0.177x +80.58%
2008-12-31 CHF1.79 Billion
≈ $2.26 Billion
CHF175.00 Million
≈ $221.25 Million
0.098x -72.54%
2007-12-31 CHF1.81 Billion
≈ $2.29 Billion
CHF644.00 Million
≈ $814.19 Million
0.356x +34.68%
2006-12-31 CHF1.61 Billion
≈ $2.03 Billion
CHF425.00 Million
≈ $537.31 Million
0.264x -4.59%
2005-12-31 CHF1.49 Billion
≈ $1.88 Billion
CHF413.00 Million
≈ $522.14 Million
0.277x +100.10%
2004-12-31 CHF1.28 Billion
≈ $1.62 Billion
CHF178.00 Million
≈ $225.04 Million
0.139x --

About Lonza Group AG

SW:LONN Switzerland Diagnostics & Research
Market Cap
$49.80 Billion
CHF39.39 Billion CHF
Market Cap Rank
#781 Global
#13 in Switzerland
Share Price
CHF564.00
Change (1 day)
-0.18%
52-Week Range
CHF467.40 - CHF588.60
All Time High
CHF769.70
About

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biol… Read more